A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
Clinical trial NCT02963168 · UNKNOWN
Trial details
- NCT number
- NCT02963168
- Sponsor
- Athenex, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2020-03-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.